Sort   by:  
 Page size 
TranscriptomicsTET2 mutations are associated with specific methylation profiles in patients with Chronic Myelomonocytic Leukemia
Chronic myelomonocytic leukemia (CMML) has recently been associated with a high incidence of diverse mutations in genes implicated in epigenetic mechanisms such as TET2 or EZH2. We have performed genome-wide methylation arrays and mutational analysis of TET2, IDH1, IDH2, EZH2 and JAK2 in a group of ...
ORGANISM(S): Homo sapiens 
2012-02-13 | E-GEOD-31600 | biostudies-arrayexpress
GenomicsSpecific molecular signatures underlie response to decitabine in CMML [ERRBS]
Myelodysplastic syndromes and chronic myelomonocytic leukemia (CMML) are characterized by mutations in epigenetic modifiers and aberrant DNA methylation. DNA methyltransferase inhibitors (DMTis) are used to treat these disorders, but response is highly variable with few means to predict which patien...
ORGANISM(S): Homo sapiens 
2015-03-31 | E-GEOD-61161 | biostudies-arrayexpress
TranscriptomicsSpecific molecular signatures underlie response to decitabine in CMML [RNA-seq]
Myelodysplastic syndromes and chronic myelomonocytic leukemia (CMML) are characterized by mutations in epigenetic modifiers and aberrant DNA methylation. DNA methyltransferase inhibitors (DMTis) are used to treat these disorders, but response is highly variable with few means to predict which patien...
ORGANISM(S): Homo sapiens 
2015-03-31 | E-GEOD-61162 | biostudies-arrayexpress
TranscriptomicsEffective requesting method to detect fusion transcripts in chronic myelomonocytic leukemia RNA-seq
Two sets of 10 samples from patients with CMML were used for this study. The first set (CMML11 to CMML20) includes 10 blood samples supplied by Eric Jourdan (Biological Resource Center CHU-Nimes, France). Peripheral blood mononuclear cells were separated by Ficoll-Hypaque density gradient and preser...
ORGANISM(S): Homo sapiens 
2025-07-22 | E-MTAB-13763 | biostudies-arrayexpress
GenomicsChronic myelomonocytic leukemia
Chronic myelomonocytic leukemia is an aggressive hematological malignancy with dismal outcomes, with the pCMML subtype in particular having median OS of <2 years and high rates of AML transformation (Patnaik et al., 2014). Given limited therapeutic options for affected patients, we carried out this ...
EGAS00001005107 | EGA
TranscriptomicsSpecific molecular signatures underlie response to decitabine in CMML
This SuperSeries is composed of the SubSeries listed below. Refer to individual Series
ORGANISM(S): Homo sapiens 
2015-03-31 | E-GEOD-61163 | biostudies-arrayexpress
TranscriptomicsIGR_Itzykson_CMML
Genomic studies in chronic myeloid malignancies, including myeloproliferative neoplasms (MPN), myelodysplastic syndromes (MDS) and MPN/MDS, have identified common mutations in genes encoding signaling, epigenetic, transcription and splicing factors. Analysis of 18 of these genes in a cohort of 224 c...
ORGANISM(S): Homo sapiens 
2013-01-17 | E-MTAB-1044 | biostudies-arrayexpress
TranscriptomicsTranscriptional profiling of the MV4-11 cell line treated with trabectidin or azacitidin
In order to study the effects of trabectedin in chronic myelomonocytic leukemia and in juvenile myelomonocytic leukemia, we performed whole genome transcriptional profiling of a model cell line treated under either the reference drug for CMML / JMML (Azacitidine) or trabectedin.
ORGANISM(S): Homo sapiens 
2016-12-14 | E-MTAB-2978 | biostudies-arrayexpress
GenomicsCMML Collection of WES, WGS, RNA-Seq and ERRBS data
We first performed a comprehensive analysis of the genome of 66 chronic myelomonocytic leukemia cases using whole exome (N=49) or whole genome (N=17) sequencing for paired leukemic-control DNA. Then, we realized serial analysis of whole exome sequence in 17 cases, completed with serial RNA sequencin...
EGAS00001001264 | EGA
UnknownProposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions.
Not available
S-EPMC6886439 | biostudies-literature
Sort   by:  
 Page size